Literature DB >> 17058846

Chronic urticaria: importance of a medical-psychological approach.

A M Berrino1, S Voltolini, D Fiaschi, S Pellegrini, D Bignardi, P Minale, C Troise, E Maura.   

Abstract

Chronic urticaria is often associated with psychological factors, such as depression, anxiety and stress, which may play a role not only in the genesis of the disease but also in its evolution. Aims of this study were to evaluate the utility of psychological assessments (presence of depression, impact on the quality of life and incidence of "life events" before the beginning of urticaria) in conjunction with the allergological evaluation and to provide appropriate treatment to the patients selected. Thirty subjects diagnosed as Chronic Urticaria patients were submitted to psychological assessments (semi structured interview, Beck Depression Inventory, Nottingham health Profile and Dermatology Life Quality Index). The results of the evaluation show that most of the patients experienced a "stressor" event within the six months before the onset of the cutaneous manifestation. The incidence of depression resulted very high in comparison with the general population and in three cases at a severe level. The impact on the quality of life results to be moderate, but involving different fields of life (physical image, social life, quality of sleeping and eating, etc). Despite these results, only six patients accepted to be assigned to an appropriate treatment. In conclusion, we demonstrate the usefulness of a medical- psychological approach in chronic urticaria and we confirmed the resistance of psychosomatic patients to undergo psychological treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17058846

Source DB:  PubMed          Journal:  Eur Ann Allergy Clin Immunol        ISSN: 1764-1489


  9 in total

1.  [Sociomedical implications of the inability to commute in patients with cold urticaria].

Authors:  W Nürnberg; J Grabbe; H-J Glawe; R Stoll
Journal:  Hautarzt       Date:  2010-03       Impact factor: 0.751

2.  [Chronic urticaria. Prevalence, course, prognostic factors and impact].

Authors:  K Weller; S Altrichter; E Ardelean; K Krause; M Magerl; M Metz; F Siebenhaar; M Maurer
Journal:  Hautarzt       Date:  2010-09       Impact factor: 0.751

3.  Improving of psychological status and inflammatory biomarkers during omalizumab for chronic spontaneous urticaria.

Authors:  Laura Diluvio; Arianna Piccolo; Francesco Marasco; Laura Vollono; Caterina Lanna; Barbara Chiaramonte; Cinzia Niolu; Elena Campione; Luca Bianchi
Journal:  Future Sci OA       Date:  2020-08-10

4.  A comparison of mindfulness-based stress reduction and an active control in modulation of neurogenic inflammation.

Authors:  Melissa A Rosenkranz; Richard J Davidson; Donal G Maccoon; John F Sheridan; Ned H Kalin; Antoine Lutz
Journal:  Brain Behav Immun       Date:  2012-10-22       Impact factor: 7.217

5.  Temperament and character profiles of patients with chronic idiopathic urticaria.

Authors:  Sevil Alan; Fatih Canan; Ayşe Akman Karakaş; Nihal Geçici
Journal:  Postepy Dermatol Alergol       Date:  2015-06-10       Impact factor: 1.837

6.  What is new in the psychology of chronic itch?

Authors:  Andrea W M Evers; Kaya J Peerdeman; Antoinette I M van Laarhoven
Journal:  Exp Dermatol       Date:  2019-08-13       Impact factor: 3.960

7.  Treating chronic spontaneous urticaria using a brief 'whole person' treatment approach: a proof-of-concept study.

Authors:  Karen Lindsay; Josie Goulding; Margot Solomon; Brian Broom
Journal:  Clin Transl Allergy       Date:  2015-12-02       Impact factor: 5.871

8.  Stress, itch and quality of life in chronic urticaria females.

Authors:  Alicja Ograczyk-Piotrowska; Zofia Gerlicz-Kowalczuk; Anna Pietrzak; Anna M Zalewska-Janowska
Journal:  Postepy Dermatol Alergol       Date:  2018-04-24       Impact factor: 1.837

Review 9.  Neuro-Immune Circuits Regulate Immune Responses in Tissues and Organ Homeostasis.

Authors:  Manuel O Jakob; Shaira Murugan; Christoph S N Klose
Journal:  Front Immunol       Date:  2020-03-20       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.